Cells under all conditions synthesized detectable levels of sGAG, with significant increases in retained sGAG (normalized to DNA) seen after TGF-β stimulation in both BM-MSCs and AD-MSCs, and after both TGF-β and GDF6 stimulation in AD-MSCs. The gene discussed is TGFB1; the disease is Alzheimer disease.